Why R&D innovation holds the key to greater patient impact
European Pharmaceutical Review
MAY 2, 2023
Expanding this approach to simultaneously build capabilities and clinical trials in developing and underserved regions, like APAC and less wealthy healthcare systems in Latin America and Europe, is essential to driving more comprehensive clinical programmes and health equity.
Let's personalize your content